Translational Development Acquisition Corp
NASDAQ:TDAC
Cash Flow Statement
Cash Flow Statement
Translational Development Acquisition Corp
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(0)
|
1
|
3
|
5
|
|
| Other Non-Cash Items |
(0)
|
(2)
|
(4)
|
(6)
|
|
| Change in Working Capital |
(1)
|
(1)
|
(0)
|
(0)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
-27%
|
(1)
-16%
|
(1)
-4%
|
|
| Investing Cash Flow | |||||
| Other Items |
(174)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(174)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
169
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
0
|
0
|
(1)
|
|
| Other |
7
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
176
N/A
|
0
N/A
|
0
N/A
|
175
N/A
|
|
| Change in Cash | |||||
| Net Change in Cash |
0
N/A
|
0
-53%
|
(0)
N/A
|
(0)
-381%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(1)
N/A
|
(1)
-27%
|
(1)
-16%
|
(1)
-4%
|
|